Keywords: Astellas, Darexaban, Anticoagulant, Inceased bleeding, ESC

RUBY-1 trial shows Astellas’ blood thinner darexaban increases bleeding

Article | 01 September 2011

Print This

A Phase II dose-finding study has found that the new oral Factor Xa inhibitor darexaban, under development by Japanese drug ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in